Physiomics Share Price Prediction (2025-2030): Expert Analysis & Predictions

About Physiomics plc - Physiomics specialises in integrating modelling & simulation, biostatistics, data science and bio-informatics to streamline drug development. Its proprietary Virtual Tumour platform helps pharma and biotech partners such as Merck KGaA, Astellas and Bicycle Therapeutics de-risk decisions from discovery to the clinic—over 100 commercial projects to date.

Physiomics share price forecast today UK & tomorrow

• Today (intraday): technical indicators show a tight 0.400 p–0.420 p band; momentum remains neutral after a −1.2 % dip.
• Tomorrow: barring unexpected RNS, our model pins the most probable range at 0.40 p–0.43 p, reflecting typical ±3 % AIM day-to-day volatility.

These micro-forecasts are far more sensitive to news flow than the long-term tables above.

Physiomics Share Price Forecast Tables

Physiomics Share Price Forecast 2025

Physiomics Share Price Forecast 2026

Physiomics Share Price Forecast 2028

Conclusion - Physiomics Share Price

Physiomics’ unique modelling niche, recurring contract momentum and historically depressed valuation suggest scope for steady re-rating. Our base-case Physiomics share price prediction sees the stock edging toward 0.80 p by December 2030, a near-doubling from current levels. Yet risk-tolerant investors should balance that upside against liquidity constraints and funding requirements typical of AIM biotechs. Always couple any Physiomics share price forecast with your own research—or consult a licensed financial adviser—before committing capital.

FAQs - Physiomics Share Price